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1 Bath Centre for Pain Service, Royal National Rheumatic Diseases, Bath, UK Background: Adolescents can present with chronic pain in a range of different locations (e.g. back, abdomen, widespread) . This can have a serious impact on their mood and functioning, which can be summarized by the variable Quality of Life (QOL). However, QOL has not been examined extensively in the adolescent pain literature. One previous report suggested that QOL in this population is more closely associated with psychological variables than with pain intensity. Methods: Forty-one adolescent patients (age 15.3 years, 90% female) attending a tertiary residential pain rehabilitation programme completed a battery of self-report measures before and after treatment. Patients had relatively severe pain and long-standing disability (median 49 mths), with a range of diagnoses (primarily back pain, widespread idiopathic pain, CRPS). QOL was indexed by the PedsQL 4.0 generic module. We examined QOL in relationship to other paediatric chronic conditions, its correlation with pain and psychological variables, and changes over treatment. Results: Adolescents in this sample experienced much worse Quality of Life than in a range of comparator conditions (e.g. diabetes, asthma, oncology groups). QOL was more closely correlated with acceptance of pain than with pain intensity itself. Despite the severe and longstanding nature of pain in this group, QOL improved significantly after treatment. Conclusion: Adolescents attending a tertiary specialist centre for chronic pain have exceptionally low QOL, and poorer scores than in many other conditions that are most ostensibly more medically serious. QOL was not associated with pain intensity per se. However, it is associated with acceptance of pain, indicating that functioning is more associated with pain coping than pain itself. This very poor level of QOL can be improved by appropriately intensive and specialist treatment, despite no overall improvement in pain scores. Background: National guidance highlights the importance of pain management in patients with RA. Pain is also an important component of the DAS 28 and may persist despite the absence of inflammation. We were keen to investigate the factors influencing pain within our RA cohort. Methods: Patients with RA were recruited consecutively from the outpatient clinic. A face to face interview was performed to determine (i) whether their pain had been discussed during the consultation and (ii) their understanding and beliefs about pharmacological and nonpharmacological aspects of pain management. Demographics, past medical history, comorbidities and disease activity were also collated. Results: 31 patients (12 male and 19 female patients) were recruited with an average age of 66.6 years and a mean disease duration of 9.4 years. Patients had a mean of 3.2 comorbidities and were taking a mean of 8.5 different medications which resulted in an average of 15.4 tablets daily. Despite an overall average DAS28 of 3.1, only 7 patients (22.5%) felt their pain was managed all of the time and 13% said their pain was never controlled. The majority of patients were taking paracetamol (81%), 19% were taking NSAIDs and 58% were taking a weak opioid. Only 48% reported taking their analgesics at regular intervals. 87% said that they were able to discuss their pain in clinic but only 68% recalled having been asked how the pain impacted on their lives. Most patients felt that they had been provided with sufficient information on pain management; however, it was felt that further education about pain medications and non-pharmacological pain management techniques would be helpful. Although no correlation was seen between the numerical pain score and the DAS28, the worst pain was seen in those with poor RA control, rather than in those where pain was felt to be mainly as a result of secondary degenerative change. There was some evidence that those who felt they were given the opportunity to discuss their pain management at every visit and how it affected their life felt that their pain was better managed. The number of comorbidities and number of medications taken did not influence objective measures of pain or how well pain was managed. Although 8 patients had been referred to the pain clinic, only 3 found it helpful; whereas all 3 who had participated in the expert patient programme found it to be of benefit. Conclusion: Patients benefit from being given the opportunity to discuss pain and its impact on daily life. Pain remains a prominent feature even after inflammation is controlled. Access to pain management resources is therefore important at all stages of disease and should be as important as education on disease modifying drugs. Disclosure statement: The authors have declared no conflicts of interest. Background: Patients with chronic musculoskeletal pain are often frequent attenders at GP surgeries and hospitals. Previous research showed that patients attending our rheumatology pain clinic at University College London Hospitals (UCLH) had poor self-efficacy despite multiple previous interventions and investigations. Continuing this pattern of healthcare use is ineffective. Pain management programmes (PMP) based on cognitive behavioural therapy seek to help patients to accept that the chronic pain cannot be cured and thus to engage coping strategies to improve quality of life. We sought to investigate whether attending a pain management programme reduced the number of hospital appointments, interventions and investigations over a three year period. Methods: We reviewed the medical records of 74 patients who had attended the pain management programme at the National Hospital for Neurology and Neurosurgery, London in 2008-9. We recorded the numbers of hospital appointments, interventions (injections, physiotherapy, and acupuncture) and investigations (X-rays, scans, EMG but excluding blood tests) over the 3 years before the programme and the 3 years after it. We also recorded demographic data and main diagnosis for each patient. Results: Of the 74 patients, 60 were women and 14 were men. Mean age was 45 years (range 19-74). All types of hospital encounter were reduced in the 3 years following the PMP compared with the 3 years before, as shown in Table 1 . These reductions were seen equally in men and women and equally in people over and under 45 years old. 29 patients had joint hypermobility syndrome and attended a modified JHS-specific PMP. Similar reductions in appointments, investigations and interventions were seen in JHS and non-JHS patients. Conclusion: Attending this pain management programme led to a decrease in hospital appointments, investigations and interventions in people with chronic musculoskeletal pain. This has implications for cost-effectiveness of such programmes as they potentially reduce ineffective use of healthcare resources.
ATTENDING A PAIN MANAGEMENT PROGRAMME REDUCES HOSPITAL INVESTIGATIONS, APPOINTMENTS AND INTERVENTIONS OVER THE NEXT THREE YEARS
Disclosure statement: The authors have declared no conflicts of interest. Methods: This study aimed to identify clinical features in 40 individuals employed in computer data entry in an office-based industry, who reported symptoms resulting in medico-legal assessment (Group 1). These were compared with 1960 controls, with upper limb symptoms, randomly selected from a primary care database (Group 2). Clinical changes in both groups were recorded using a previously validated protocol. This included musculoskeletal and neurological features in the neck and upper limb. Results: Both groups were comparable in height, weight and hand dominance. There were minor differences in mean age-Group 1: 43.1 years, Group 2: 48.2 years, and in gender ratio-females; Group 1: 87.5%, Group 2: 60.4%. There were significant differences in frequency and location of symptoms between the two groups. The most marked differences involved distal more than proximal limb structures. Abnormalities were more common and severe in the right upper limb in Group 1. Forearm and wrist pain differed markedly, present in 95% on the right side in Group 1, but in 19.9% in Group 2. This was most common on the radial side of the wrist. Specific physical signs in the hands were also common in Group 1, including median nerve sensory changes (25% in right hand), thumb pain, tenderness and weakness, with or without a positive Finkelstein test, in 43.6%. Less than 10% of Group 2 showed these signs. Right elbow pain was reported in 65% of Group 1, with lateral and medial condyle tenderness in 30% and 20% compared with less than 10% of Group 2. Specific shoulder symptoms and signs were infrequent, but a diffuse pattern of shoulder pain on the right side was more frequent in Group 1 (35%) compared with less than 1% in Group 2. Neck pain was more common in Group 1: 47.5% vs 29.2% of Group 2. Conclusion: Clinical features in subjects with a work-related upper limb disorder differed significantly from randomly selected community subjects with upper limb symptoms. In the distal upper limb, the workrelated group showed more forearm and wrist pain and dysfunction and more elbow pain and epicondyle tenderness. Proximal upper limb changes did not differ significantly between the two groups. Changes were more common and severe on the right side, consistent with hand dominance and manual aspects of computer use. 
UPPER LIMB DISORDERS IN COMPUTER KEYBOARD OPERATIVES: COMPARISON OF CLINICAL FEATURES WITH COMMUNITY-DERIVED CONTROLS

